Dogwood Therapeutics holders back charter amendment
Dogwood Therapeutics, Inc. held its annual stockholder meeting, where investors approved an amendment to the Certificate of Incorporation to increase the number of authorized common and preferred shares.
Rhea-AI Filing Summary
Dogwood Therapeutics, Inc. held its annual stockholder meeting, where investors approved an amendment to the Certificate of Incorporation to increase the number of authorized common and preferred shares. Stockholders also elected seven directors, ratified Forvis Mazars, LLP as auditor for 2026, and endorsed executive pay.
Holders of 31,791,500 common shares, representing 95.17% of the voting power as of the record date, were present in person or by proxy, providing a strong quorum. Stockholders supported holding advisory votes on executive compensation every year, and the Board agreed to include this annual vote in future proxy materials.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.03, 5.07, 9.01
3 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Shares represented at meeting: 31,791,500 shares
Voting power represented: 95.17%
Auditor ratification - For votes: 31,778,192 votes
+4 more
7 metrics
Shares represented at meeting
31,791,500 shares
Common stock present or by proxy at annual meeting
Voting power represented
95.17%
Voting power of common stock as of April 21, 2026 record date
Auditor ratification - For votes
31,778,192 votes
Ratification of Forvis Mazars, LLP for fiscal year 2026
Auditor ratification - Against votes
2,397 votes
Opposition to Forvis Mazars, LLP ratification
Charter amendment - For votes
28,431,012 votes
Approval to increase authorized common and preferred shares
Say-on-Frequency one-year option
28,682,394 votes
Support for annual advisory vote on executive compensation
Say-on-Pay - For votes
28,662,176 votes
Advisory approval of named executive officer compensation
Key Terms
certificate of amendment, Certificate of Incorporation, broker non-vote, Say-on-Frequency, +2 more
6 terms
certificate of amendment regulatory
"The Company filed a certificate of amendment to the Certificate of Incorporation"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
Certificate of Incorporation regulatory
"approved the amendment to the Company’s Certificate of Incorporation"
A certificate of incorporation is an official government document that creates a corporation and records key facts such as its legal name, basic governance structure, and stock authorization—think of it as a company's birth certificate plus its basic rulebook. Investors care because it establishes the company’s legal existence, limits owners’ personal liability, and sets the framework for issuing shares and enforcing shareholder rights, which affects ownership, control and the company’s ability to raise capital.
broker non-vote financial
"For 28,684,078 | 7,501 | 3,099,921 Broker Non-Vote"
A broker non-vote happens when a brokerage firm holds shares in street name for a client but does not cast a ballot on a particular shareholder item because the broker lacks discretionary authority to vote that matter. Think of it like a person who owns a ticket but the ticket-holder refuses to vote on some issues; the share counts for ownership but not for that vote, which can affect whether proposals reach the required number of votes or a quorum.
Say-on-Frequency financial
"advisory vote on the frequency of future advisory votes on named executive officer compensation (“Say-on-Frequency” proposal)"
Say-on-Pay financial
"Advisory vote on the compensation of our named executive officers (“Say-on-Pay” proposal)"
A say-on-pay is a shareholder vote that gives investors a chance to approve or disapprove a company’s executive compensation packages, typically held at annual meetings. It matters because the vote signals investor satisfaction with how leaders are paid—like customers rating how well managers are rewarded—and can push boards to change pay plans, reducing governance risk and affecting investor confidence and stock value even though the vote is usually advisory rather than legally binding.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Dogwood Therapeutics (DWTX) stockholders approve at the 2026 annual meeting?
Stockholders approved an amendment to increase authorized common and preferred shares, elected seven directors, ratified Forvis Mazars, LLP as auditor for 2026, and supported advisory Say-on-Pay and Say-on-Frequency proposals, confirming the company’s governance and capital structure plans.
What charter change did Dogwood Therapeutics (DWTX) stockholders approve?
Stockholders approved an amendment to the Certificate of Incorporation to increase the number of authorized common and preferred shares. The company filed a certificate of amendment in Delaware, which became effective upon filing on June 17, 2026.
Which auditor did Dogwood Therapeutics (DWTX) stockholders ratify for 2026?
Stockholders ratified Forvis Mazars, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The ratification received strong support, with 31,778,192 votes for and minimal opposition or abstentions recorded.
What Say-on-Frequency choice did Dogwood Therapeutics (DWTX) investors support?
Investors backed holding Say-on-Pay advisory votes every one year, with 28,682,394 votes for that option. The Board adopted this preference and will include an annual advisory vote on executive compensation until the next required frequency vote.
Did Dogwood Therapeutics (DWTX) stockholders approve Say-on-Pay in 2026?
Yes. Stockholders approved the advisory Say-on-Pay proposal with 28,662,176 votes for, 25,962 against, and 3,441 abstentions. This advisory support reflects stockholder agreement with the company’s named executive officer compensation program.
AI-generated analysis. How Rhea-AI works. Not financial advice.
